Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb6
|
ENSMUSG00000000690.4 | homeobox B6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_96290565_96290750 | Hoxb6 | 1819 | 0.129736 | -0.36 | 7.6e-03 | Click! |
chr11_96299399_96299550 | Hoxb6 | 303 | 0.726953 | -0.34 | 1.2e-02 | Click! |
chr11_96298909_96299317 | Hoxb6 | 58 | 0.920584 | -0.32 | 1.7e-02 | Click! |
chr11_96292363_96292539 | Hoxb6 | 25 | 0.928920 | -0.32 | 1.8e-02 | Click! |
chr11_96292004_96292155 | Hoxb6 | 397 | 0.633545 | -0.25 | 6.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_62807459_62807865 | 7.85 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr3_141936600_141936978 | 7.02 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5266 |
0.33 |
chr12_49945819_49946221 | 6.96 |
Gm7481 |
predicted gene 7481 |
104269 |
0.08 |
chr17_73507966_73508157 | 6.36 |
AC107792.1 |
Novel transcript |
9694 |
0.17 |
chr1_94503928_94504626 | 5.88 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr3_35405107_35405293 | 5.67 |
Gm43078 |
predicted gene 43078 |
8633 |
0.26 |
chr1_13936038_13936249 | 5.65 |
Gm36947 |
predicted gene, 36947 |
87024 |
0.09 |
chr13_79765398_79765578 | 5.43 |
Gm48471 |
predicted gene, 48471 |
72589 |
0.12 |
chr4_86183975_86184194 | 5.38 |
Adamtsl1 |
ADAMTS-like 1 |
15233 |
0.29 |
chr13_36724536_36725119 | 5.27 |
Gm30177 |
predicted gene, 30177 |
2431 |
0.23 |
chr13_84566286_84566489 | 5.21 |
Gm26913 |
predicted gene, 26913 |
124554 |
0.06 |
chr12_26635257_26635560 | 5.13 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr12_44462981_44463367 | 4.93 |
Nrcam |
neuronal cell adhesion molecule |
6514 |
0.25 |
chr1_24245817_24245999 | 4.86 |
Col9a1 |
collagen, type IX, alpha 1 |
16391 |
0.25 |
chr19_15340816_15341006 | 4.75 |
Gm24319 |
predicted gene, 24319 |
339093 |
0.01 |
chr8_53600519_53600706 | 4.64 |
Neil3 |
nei like 3 (E. coli) |
9007 |
0.27 |
chr12_56441331_56441482 | 4.56 |
Gm18027 |
predicted gene, 18027 |
30849 |
0.13 |
chr18_29267767_29267918 | 4.54 |
Gm34743 |
predicted gene, 34743 |
22495 |
0.28 |
chr5_113690085_113690274 | 4.50 |
1700069L16Rik |
RIKEN cDNA 1700069L16 gene |
14269 |
0.13 |
chr3_81830078_81830229 | 4.43 |
A830029E22Rik |
RIKEN cDNA A830029E22 gene |
28128 |
0.18 |
chr4_23994381_23994540 | 4.38 |
Gm28448 |
predicted gene 28448 |
60506 |
0.16 |
chr18_15544080_15544457 | 4.35 |
Aqp4 |
aquaporin 4 |
133286 |
0.05 |
chr14_75473590_75473918 | 4.30 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17772 |
0.22 |
chr3_134302602_134302962 | 4.28 |
Gm43559 |
predicted gene 43559 |
30272 |
0.13 |
chr5_15850216_15850406 | 4.28 |
Gm42453 |
predicted gene 42453 |
19936 |
0.14 |
chr3_50014297_50014449 | 4.27 |
Gm37854 |
predicted gene, 37854 |
12401 |
0.22 |
chr6_107654219_107654371 | 4.26 |
4933431M02Rik |
RIKEN cDNA 4933431M02 gene |
26521 |
0.24 |
chr13_84569455_84569857 | 4.25 |
Gm26913 |
predicted gene, 26913 |
121285 |
0.06 |
chr17_48999548_48999943 | 4.22 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
67366 |
0.11 |
chr6_89613385_89613634 | 4.21 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
17857 |
0.17 |
chr9_50064901_50065078 | 4.20 |
Gm47543 |
predicted gene, 47543 |
110111 |
0.06 |
chr18_35215250_35215438 | 4.17 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
320 |
0.55 |
chr2_153425549_153426538 | 4.07 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr3_141937004_141937205 | 4.07 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5581 |
0.33 |
chr2_105674521_105675719 | 3.98 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr10_39571032_39571302 | 3.97 |
Gm16364 |
predicted gene 16364 |
13105 |
0.17 |
chr1_9583969_9584225 | 3.97 |
Gm6161 |
predicted gene 6161 |
9549 |
0.13 |
chr17_93312930_93313224 | 3.95 |
Gm9665 |
predicted gene 9665 |
4184 |
0.24 |
chr13_110492570_110492721 | 3.88 |
Plk2 |
polo like kinase 2 |
94848 |
0.08 |
chr4_56411407_56411577 | 3.87 |
Gm12518 |
predicted gene 12518 |
23690 |
0.26 |
chr17_3611352_3611547 | 3.82 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53580 |
0.12 |
chr6_135112396_135112681 | 3.82 |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
5708 |
0.14 |
chr9_23062142_23062343 | 3.82 |
Bmper |
BMP-binding endothelial regulator |
160834 |
0.04 |
chr1_79452501_79452662 | 3.81 |
Scg2 |
secretogranin II |
12461 |
0.23 |
chr13_29416392_29416761 | 3.78 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
58031 |
0.16 |
chr14_65423425_65423581 | 3.76 |
Pnoc |
prepronociceptin |
1657 |
0.39 |
chr15_70156585_70156736 | 3.75 |
Gm5216 |
predicted gene 5216 |
91991 |
0.1 |
chr9_41586632_41586783 | 3.75 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1062 |
0.35 |
chr4_24669747_24669918 | 3.67 |
Klhl32 |
kelch-like 32 |
5595 |
0.3 |
chr15_74157437_74157616 | 3.60 |
Gm15387 |
predicted gene 15387 |
63193 |
0.12 |
chr7_78885496_78885685 | 3.55 |
Mir7-2 |
microRNA 7-2 |
2687 |
0.17 |
chr2_178143087_178143316 | 3.54 |
Phactr3 |
phosphatase and actin regulator 3 |
1268 |
0.55 |
chr8_86961747_86962117 | 3.52 |
Gm24781 |
predicted gene, 24781 |
3687 |
0.2 |
chr10_87486341_87486591 | 3.49 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7194 |
0.2 |
chr2_137229757_137229948 | 3.47 |
Gm28214 |
predicted gene 28214 |
30869 |
0.21 |
chr14_118230141_118230337 | 3.47 |
Gm4675 |
predicted gene 4675 |
5993 |
0.14 |
chr7_78190922_78191313 | 3.44 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
1626 |
0.44 |
chr8_90536167_90536332 | 3.43 |
Gm45639 |
predicted gene 45639 |
138709 |
0.04 |
chr10_57822502_57822860 | 3.42 |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
28113 |
0.17 |
chr13_69933271_69934031 | 3.42 |
4933416O17Rik |
RIKEN cDNA 4933416O17 gene |
26182 |
0.17 |
chr2_38621804_38622039 | 3.41 |
Gm13586 |
predicted gene 13586 |
880 |
0.48 |
chr1_84910597_84910760 | 3.39 |
Slc16a14 |
solute carrier family 16 (monocarboxylic acid transporters), member 14 |
24179 |
0.12 |
chr9_91365711_91366045 | 3.38 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr7_93038226_93038402 | 3.32 |
Gm26862 |
predicted gene, 26862 |
31332 |
0.13 |
chr19_21781154_21781434 | 3.30 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
2906 |
0.29 |
chr10_109684839_109685035 | 3.30 |
3110043J17Rik |
RIKEN cDNA 3110043J17 gene |
36158 |
0.19 |
chr17_50906233_50906384 | 3.30 |
Gm25177 |
predicted gene, 25177 |
10733 |
0.28 |
chr6_50776382_50776589 | 3.29 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
161 |
0.95 |
chr13_47414261_47414412 | 3.26 |
Gm35733 |
predicted gene, 35733 |
52950 |
0.15 |
chr10_31873449_31873894 | 3.23 |
Gm47704 |
predicted gene, 47704 |
5759 |
0.31 |
chr1_20428362_20428787 | 3.21 |
Gm15795 |
predicted gene 15795 |
16236 |
0.17 |
chr1_20069822_20069974 | 3.20 |
Gm37315 |
predicted gene, 37315 |
4350 |
0.36 |
chr6_111913920_111914071 | 3.18 |
Gm44192 |
predicted gene, 44192 |
174199 |
0.03 |
chr10_87473625_87473776 | 3.17 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
19960 |
0.18 |
chr16_77594599_77594896 | 3.17 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
155 |
0.91 |
chr9_47858873_47859024 | 3.17 |
Gm47197 |
predicted gene, 47197 |
82211 |
0.08 |
chr9_99744585_99744739 | 3.15 |
Gm23949 |
predicted gene, 23949 |
5855 |
0.19 |
chr6_142781097_142781248 | 3.15 |
Cmas |
cytidine monophospho-N-acetylneuraminic acid synthetase |
11206 |
0.17 |
chr17_30860409_30860564 | 3.13 |
Gm41561 |
predicted gene, 41561 |
3050 |
0.14 |
chr6_101422696_101422871 | 3.12 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
44886 |
0.13 |
chr13_95639614_95639765 | 3.12 |
F2r |
coagulation factor II (thrombin) receptor |
21202 |
0.13 |
chr10_52577862_52578221 | 3.12 |
Gm36065 |
predicted gene, 36065 |
15971 |
0.14 |
chr1_171280638_171281373 | 3.10 |
Ppox |
protoporphyrinogen oxidase |
114 |
0.89 |
chr10_87666438_87666755 | 3.09 |
Gm48195 |
predicted gene, 48195 |
21982 |
0.23 |
chr9_56738591_56739084 | 3.06 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr11_24740164_24740317 | 3.06 |
Gm10466 |
predicted gene 10466 |
9518 |
0.27 |
chr19_14777449_14777621 | 3.06 |
Gm26026 |
predicted gene, 26026 |
59055 |
0.15 |
chr11_33670175_33670394 | 3.05 |
Kcnip1 |
Kv channel-interacting protein 1 |
10287 |
0.18 |
chr14_55116352_55116664 | 3.04 |
Jph4 |
junctophilin 4 |
72 |
0.94 |
chr7_101237158_101237309 | 3.04 |
Gm47324 |
predicted gene, 47324 |
985 |
0.48 |
chr7_50924518_50924745 | 3.01 |
Gm9343 |
predicted gene 9343 |
18523 |
0.15 |
chr11_92135322_92135532 | 2.99 |
Gm22702 |
predicted gene, 22702 |
111014 |
0.08 |
chr12_29526481_29526772 | 2.99 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr6_54447461_54447612 | 2.99 |
Wipf3 |
WAS/WASL interacting protein family, member 3 |
5347 |
0.19 |
chr6_14720581_14720777 | 2.99 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
34595 |
0.23 |
chr2_96401290_96401481 | 2.97 |
Lrrc4c |
leucine rich repeat containing 4C |
83169 |
0.11 |
chr5_66918045_66918260 | 2.97 |
Gm43281 |
predicted gene 43281 |
2144 |
0.26 |
chr19_59465967_59466144 | 2.95 |
Emx2 |
empty spiracles homeobox 2 |
3253 |
0.21 |
chr12_33035439_33035619 | 2.94 |
Cdhr3 |
cadherin-related family member 3 |
17457 |
0.14 |
chr5_111220876_111221370 | 2.94 |
Ttc28 |
tetratricopeptide repeat domain 28 |
4335 |
0.22 |
chr16_90298727_90298878 | 2.93 |
Scaf4 |
SR-related CTD-associated factor 4 |
14299 |
0.14 |
chr5_107498215_107498366 | 2.91 |
Btbd8 |
BTB (POZ) domain containing 8 |
511 |
0.68 |
chr17_94054499_94054685 | 2.90 |
Gm50004 |
predicted gene, 50004 |
77679 |
0.12 |
chr7_83203707_83204363 | 2.90 |
5930435M05Rik |
RIKEN cDNA 5930435M05 gene |
2449 |
0.29 |
chr16_76866459_76866678 | 2.90 |
1700041M19Rik |
RIKEN cDNA 1700041M19 gene |
22713 |
0.18 |
chr2_70202586_70203174 | 2.90 |
Myo3b |
myosin IIIB |
106582 |
0.06 |
chr11_40573037_40573231 | 2.88 |
Gm12136 |
predicted gene 12136 |
2609 |
0.29 |
chr8_70118830_70119054 | 2.88 |
Ncan |
neurocan |
1931 |
0.15 |
chr2_14535212_14535413 | 2.87 |
Gm13266 |
predicted gene 13266 |
22713 |
0.16 |
chr9_122416881_122417032 | 2.86 |
Gm47128 |
predicted gene, 47128 |
5180 |
0.15 |
chr1_186182701_186182910 | 2.84 |
Gm37272 |
predicted gene, 37272 |
548 |
0.77 |
chr8_38766754_38766905 | 2.83 |
AC163680.1 |
NADH-ubiquinone oxidoreductase pseudogene |
28277 |
0.23 |
chr4_106103909_106104107 | 2.83 |
Gm12729 |
predicted gene 12729 |
1060 |
0.48 |
chr14_24617341_24617911 | 2.83 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr14_9337124_9337300 | 2.81 |
Gm48370 |
predicted gene, 48370 |
63412 |
0.15 |
chr12_76781109_76781265 | 2.81 |
Churc1 |
churchill domain containing 1 |
12699 |
0.14 |
chr13_107309340_107309491 | 2.80 |
Gm2726 |
predicted gene 2726 |
29224 |
0.19 |
chr4_15385357_15385571 | 2.79 |
Gm24317 |
predicted gene, 24317 |
2316 |
0.4 |
chr1_80512710_80512861 | 2.78 |
Dock10 |
dedicator of cytokinesis 10 |
6475 |
0.23 |
chr5_70842284_70842796 | 2.77 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr10_25571569_25571731 | 2.76 |
Gm29571 |
predicted gene 29571 |
35264 |
0.13 |
chr8_34377241_34377395 | 2.76 |
Gm33831 |
predicted gene, 33831 |
8510 |
0.15 |
chr14_47890672_47890828 | 2.75 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
8101 |
0.19 |
chr3_79146093_79146259 | 2.74 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
301 |
0.92 |
chr6_112838665_112838827 | 2.74 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
9287 |
0.23 |
chr9_110053315_110053992 | 2.74 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr13_84805083_84805258 | 2.73 |
Gm26913 |
predicted gene, 26913 |
114229 |
0.06 |
chr11_26981330_26981481 | 2.71 |
Gm12074 |
predicted gene 12074 |
70292 |
0.11 |
chr9_27454354_27454543 | 2.70 |
Spata19 |
spermatogenesis associated 19 |
56923 |
0.12 |
chr18_85288938_85289089 | 2.69 |
Gm50370 |
predicted gene, 50370 |
217177 |
0.02 |
chr13_88088380_88088544 | 2.69 |
Gm27044 |
predicted gene, 27044 |
96994 |
0.08 |
chr9_63523931_63524082 | 2.68 |
Gm16759 |
predicted gene, 16759 |
7346 |
0.22 |
chr1_42691969_42692512 | 2.68 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr2_4036647_4036830 | 2.67 |
Gm2639 |
predicted gene 2639 |
15821 |
0.14 |
chr12_47164470_47164875 | 2.67 |
Gm36971 |
predicted gene, 36971 |
370 |
0.91 |
chr6_140962609_140962796 | 2.66 |
Gm30524 |
predicted gene, 30524 |
7067 |
0.26 |
chr7_84402158_84402326 | 2.64 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
7641 |
0.18 |
chr2_53501719_53501931 | 2.63 |
Gm13503 |
predicted gene 13503 |
50101 |
0.17 |
chr8_122804038_122804246 | 2.62 |
Gm45743 |
predicted gene 45743 |
21944 |
0.08 |
chr3_42892344_42892576 | 2.61 |
Gm38044 |
predicted gene, 38044 |
306861 |
0.01 |
chr5_148152885_148153053 | 2.60 |
Gm10167 |
predicted pseudogene 10167 |
31408 |
0.18 |
chr16_67183025_67183176 | 2.59 |
Gm49640 |
predicted gene, 49640 |
55250 |
0.18 |
chr18_56152912_56153063 | 2.59 |
Gm23555 |
predicted gene, 23555 |
40012 |
0.17 |
chr14_121219644_121219834 | 2.58 |
B930095G15Rik |
RIKEN cDNA B930095G15 gene |
28967 |
0.18 |
chr9_34334961_34335112 | 2.57 |
Gm47858 |
predicted gene, 47858 |
124145 |
0.05 |
chr11_88280427_88280609 | 2.57 |
Ccdc182 |
coiled-coil domain containing 182 |
13540 |
0.16 |
chr13_71507941_71508418 | 2.57 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr8_12214609_12214908 | 2.56 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
64061 |
0.1 |
chr3_135887651_135887876 | 2.54 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
3603 |
0.16 |
chr12_41315207_41315374 | 2.54 |
Gm47376 |
predicted gene, 47376 |
32800 |
0.17 |
chr18_72022988_72023179 | 2.53 |
Dcc |
deleted in colorectal carcinoma |
327934 |
0.01 |
chr15_16728489_16728641 | 2.52 |
Cdh9 |
cadherin 9 |
191 |
0.97 |
chr15_53343151_53343512 | 2.52 |
Ext1 |
exostosin glycosyltransferase 1 |
2328 |
0.4 |
chr2_21010157_21010628 | 2.52 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr11_14059231_14059425 | 2.51 |
Gm12005 |
predicted gene 12005 |
102751 |
0.08 |
chr3_146769028_146769237 | 2.51 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
1129 |
0.48 |
chr12_26886622_26886951 | 2.51 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
51913 |
0.18 |
chr3_128797915_128798079 | 2.51 |
Gm4410 |
predicted gene 4410 |
41839 |
0.18 |
chr2_125704867_125705284 | 2.50 |
Shc4 |
SHC (Src homology 2 domain containing) family, member 4 |
18312 |
0.18 |
chr6_112833784_112834069 | 2.50 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
4467 |
0.26 |
chr4_137706367_137706819 | 2.49 |
Rap1gapos |
RAP1 GTPase activating protein, opposite strand |
13 |
0.95 |
chr5_97194981_97195147 | 2.48 |
Gm2861 |
predicted gene 2861 |
522 |
0.8 |
chr13_110166772_110166959 | 2.48 |
Rab3c |
RAB3C, member RAS oncogene family |
113285 |
0.06 |
chr4_12307295_12307478 | 2.47 |
Gm11846 |
predicted gene 11846 |
35987 |
0.18 |
chr8_48509354_48509578 | 2.47 |
Tenm3 |
teneurin transmembrane protein 3 |
45847 |
0.19 |
chr8_45715387_45715853 | 2.46 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
27283 |
0.17 |
chr12_40596567_40596718 | 2.44 |
Dock4 |
dedicator of cytokinesis 4 |
150306 |
0.04 |
chr12_4342317_4342468 | 2.43 |
Ncoa1 |
nuclear receptor coactivator 1 |
2078 |
0.29 |
chr14_14885989_14886140 | 2.43 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
20842 |
0.23 |
chr13_96011209_96011413 | 2.43 |
Sv2c |
synaptic vesicle glycoprotein 2c |
21085 |
0.19 |
chr6_65765173_65765427 | 2.42 |
Gm15490 |
predicted gene 15490 |
7364 |
0.17 |
chr10_92091964_92092115 | 2.42 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
11750 |
0.2 |
chr14_122882854_122883059 | 2.42 |
Pcca |
propionyl-Coenzyme A carboxylase, alpha polypeptide |
3947 |
0.22 |
chr9_45676646_45676829 | 2.42 |
Dscaml1 |
DS cell adhesion molecule like 1 |
3900 |
0.23 |
chr3_9750845_9751069 | 2.41 |
Gm16337 |
predicted gene 16337 |
6650 |
0.23 |
chr3_127713195_127713375 | 2.41 |
1500005C15Rik |
RIKEN cDNA 1500005C15 gene |
3742 |
0.13 |
chr1_186435679_186435845 | 2.41 |
Gm37491 |
predicted gene, 37491 |
88447 |
0.09 |
chr4_150606854_150607088 | 2.41 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
8444 |
0.2 |
chr8_33139056_33139207 | 2.39 |
Gm6877 |
predicted pseudogene 6877 |
53165 |
0.15 |
chr16_63967539_63967690 | 2.39 |
Gm49627 |
predicted gene, 49627 |
12484 |
0.3 |
chr2_83825530_83825681 | 2.39 |
Fam171b |
family with sequence similarity 171, member B |
12969 |
0.16 |
chr10_46826123_46826274 | 2.39 |
Gm25650 |
predicted gene, 25650 |
12309 |
0.24 |
chr13_95774985_95775175 | 2.39 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
10683 |
0.19 |
chr10_14196014_14196199 | 2.38 |
Gm48843 |
predicted gene, 48843 |
909 |
0.53 |
chr18_85289694_85289845 | 2.38 |
Gm50370 |
predicted gene, 50370 |
217933 |
0.02 |
chr14_118230432_118230634 | 2.38 |
Gm4675 |
predicted gene 4675 |
5699 |
0.14 |
chr12_89036096_89036273 | 2.37 |
Nrxn3 |
neurexin III |
82785 |
0.1 |
chr18_69500148_69500331 | 2.37 |
Tcf4 |
transcription factor 4 |
431 |
0.89 |
chr1_40789051_40789206 | 2.36 |
Mfsd9 |
major facilitator superfamily domain containing 9 |
1529 |
0.35 |
chr12_51241196_51241415 | 2.36 |
Rps11-ps4 |
ribosomal protein S11, pseudogene 4 |
56182 |
0.14 |
chr19_53360830_53360981 | 2.35 |
Mxi1 |
MAX interactor 1, dimerization protein |
9118 |
0.13 |
chr14_123065846_123066009 | 2.35 |
AA536875 |
expressed sequence AA536875 |
22645 |
0.22 |
chr11_52447248_52447521 | 2.35 |
Gm12209 |
predicted gene 12209 |
31719 |
0.13 |
chr6_40431416_40431824 | 2.35 |
Dennd11 |
DENN domain containing 11 |
212 |
0.91 |
chr2_56257440_56257969 | 2.34 |
Gm13518 |
predicted gene 13518 |
217851 |
0.02 |
chr1_175492264_175493051 | 2.34 |
Rgs7 |
regulator of G protein signaling 7 |
157 |
0.97 |
chr7_19695060_19695492 | 2.34 |
Apoe |
apolipoprotein E |
2355 |
0.11 |
chr2_101296435_101296598 | 2.34 |
Gm20693 |
predicted gene 20693 |
274108 |
0.01 |
chr13_100731356_100731507 | 2.33 |
Cdk7 |
cyclin-dependent kinase 7 |
492 |
0.71 |
chr10_38357833_38358251 | 2.31 |
Gm48197 |
predicted gene, 48197 |
44196 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.3 | 4.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.0 | 2.9 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.9 | 2.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.6 | 3.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.6 | 3.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.6 | 1.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 1.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 1.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 0.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 1.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 8.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 1.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 3.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 1.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 2.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.3 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 3.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 1.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.5 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.3 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 1.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.6 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 0.6 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 1.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 1.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.6 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 3.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.0 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 1.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.2 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.9 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 1.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.4 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.8 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.1 | 0.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 1.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.4 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.6 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.3 | GO:0061548 | ganglion development(GO:0061548) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 6.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.9 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 1.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.1 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.1 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 1.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 2.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 2.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 1.1 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.0 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 4.0 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.8 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 2.3 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.1 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.0 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.0 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.0 | 0.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.3 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.0 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.4 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.0 | 0.1 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.0 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 0.0 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 1.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.0 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.0 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.3 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.0 | 0.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 1.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 0.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 5.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 3.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 1.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 3.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 5.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 2.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 2.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 3.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 4.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 3.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 2.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 9.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 5.0 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 2.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 2.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 3.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.9 | 3.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.8 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 3.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 1.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 3.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 3.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 5.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 1.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 4.1 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.4 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.4 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 3.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 3.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 3.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.7 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 1.2 | GO:0018727 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.5 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.4 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.1 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 7.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 2.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 3.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 3.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 3.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.0 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 2.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |